▶ 調査レポート

世界の低侵襲前立腺がん手術市場予測(~2028年):レゼクトスコープ、前立腺用レトラクター、クライオアブレーション装置、カメラ&ビデオサポート、電気手術器、レーザー、その他

• 英文タイトル:Global Minimally Invasive Prostate Cancer Surgery Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の低侵襲前立腺がん手術市場予測(~2028年):レゼクトスコープ、前立腺用レトラクター、クライオアブレーション装置、カメラ&ビデオサポート、電気手術器、レーザー、その他 / Global Minimally Invasive Prostate Cancer Surgery Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 / GIR-22F20739資料のイメージです。• レポートコード:GIR-22F20739
• 出版社/出版日:GlobalInfoResearch / 2022年11月
• レポート形態:英文、PDF、92ページ
• 納品方法:Eメール(2~3営業日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
「Global Minimally Invasive Prostate Cancer Surgery Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
グローバルインフォリサーチ社の最新の調査によると、世界の低侵襲前立腺がん手術の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

低侵襲前立腺がん手術市場はタイプ(種類)とアプリケーション(用途)によって区分されます。2017年~2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・レゼクトスコープ、前立腺用レトラクター、クライオアブレーション装置、カメラ&ビデオサポート、電気手術器、レーザー、その他

アプリケーション別セグメントは次のように区分されます。
・腹腔鏡手術用ロボット、外科手術ブラキセラピー、クライオサージェリー、その他

世界の低侵襲前立腺がん手術市場の主要な市場プレーヤーは以下のとおりです。
・Angiodynamics、Profound Medical、BSD Medical Corporation、Medtronic、Ethicon Endo-Surgery、Olympus Corporation、Siemens Healthcare、Intuitive Surgical、Teleflex

地域別セグメントは次の地域・国をカバーします。
・北米市場(米国、カナダ、メキシコ)
・ヨーロッパ市場(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋市場(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南米市場(ブラジル、アルゼンチン、コロンビア)
・中東・アフリカ市場(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、低侵襲前立腺がん手術製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な低侵襲前立腺がん手術メーカーの企業概要、2019年~2022年までの低侵襲前立腺がん手術の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な低侵襲前立腺がん手術メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別低侵襲前立腺がん手術の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの低侵襲前立腺がん手術のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での低侵襲前立腺がん手術市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および低侵襲前立腺がん手術の産業チェーンを掲載しています。
・第13、14、15章では、低侵襲前立腺がん手術の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 低侵襲前立腺がん手術の概要
- タイプ別分析(2017年vs2021年vs2028年):レゼクトスコープ、前立腺用レトラクター、クライオアブレーション装置、カメラ&ビデオサポート、電気手術器、レーザー、その他
- アプリケーション別分析(2017年vs2021年vs2028年):腹腔鏡手術用ロボット、外科手術ブラキセラピー、クライオサージェリー、その他
- 世界の低侵襲前立腺がん手術市場規模・予測
- 世界の低侵襲前立腺がん手術生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Angiodynamics、Profound Medical、BSD Medical Corporation、Medtronic、Ethicon Endo-Surgery、Olympus Corporation、Siemens Healthcare、Intuitive Surgical、Teleflex
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・タイプ別分析2017年-2028年:レゼクトスコープ、前立腺用レトラクター、クライオアブレーション装置、カメラ&ビデオサポート、電気手術器、レーザー、その他
・アプリケーション別分析2017年-2028年:腹腔鏡手術用ロボット、外科手術ブラキセラピー、クライオサージェリー、その他
・低侵襲前立腺がん手術の北米市場分析
- 低侵襲前立腺がん手術の北米市場:タイプ別市場規模2017年-2028年
- 低侵襲前立腺がん手術の北米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・低侵襲前立腺がん手術のヨーロッパ市場分析
- :低侵襲前立腺がん手術のヨーロッパ市場:タイプ別市場規模2017年-2028年
- :低侵襲前立腺がん手術のヨーロッパ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・低侵襲前立腺がん手術のアジア太平洋市場分析
- 低侵襲前立腺がん手術のアジア太平洋市場:タイプ別市場規模2017年-2028年
- 低侵襲前立腺がん手術のアジア太平洋市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・低侵襲前立腺がん手術の南米市場分析
- 低侵襲前立腺がん手術の南米市場:タイプ別市場規模2017年-2028年
- 低侵襲前立腺がん手術の南米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・低侵襲前立腺がん手術の中東・アフリカ市場分析
- 低侵襲前立腺がん手術の中東・アフリカ市場:タイプ別市場規模2017年-2028年
- 低侵襲前立腺がん手術の中東・アフリカ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Minimally Invasive Prostate Cancer Surgery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Minimally Invasive Prostate Cancer Surgery market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Laparoscopy Robotics accounting for % of the Minimally Invasive Prostate Cancer Surgery global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Resectoscope segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Minimally Invasive Prostate Cancer Surgery include Angiodynamics, Profound Medical, BSD Medical Corporation, Medtronic, and Ethicon Endo-Surgery, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Minimally Invasive Prostate Cancer Surgery market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Resectoscope
Prostatic Retractor
Cryoablation Device
Cameras and Video Support
Electrosurgical Unit
Lasers
Others
Market segment by Application can be divided into
Laparoscopy Robotics
Surgery Brachytherapy Cryosurgery
Others
The key market players for global Minimally Invasive Prostate Cancer Surgery market are listed below:
Angiodynamics
Profound Medical
BSD Medical Corporation
Medtronic
Ethicon Endo-Surgery
Olympus Corporation
Siemens Healthcare
Intuitive Surgical
Teleflex
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Minimally Invasive Prostate Cancer Surgery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Minimally Invasive Prostate Cancer Surgery, with price, sales, revenue and global market share of Minimally Invasive Prostate Cancer Surgery from 2019 to 2022.
Chapter 3, the Minimally Invasive Prostate Cancer Surgery competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Minimally Invasive Prostate Cancer Surgery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Minimally Invasive Prostate Cancer Surgery market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Minimally Invasive Prostate Cancer Surgery.
Chapter 13, 14, and 15, to describe Minimally Invasive Prostate Cancer Surgery sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Minimally Invasive Prostate Cancer Surgery Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Minimally Invasive Prostate Cancer Surgery Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Resectoscope
1.2.3 Prostatic Retractor
1.2.4 Cryoablation Device
1.2.5 Cameras and Video Support
1.2.6 Electrosurgical Unit
1.2.7 Lasers
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Minimally Invasive Prostate Cancer Surgery Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Laparoscopy Robotics
1.3.3 Surgery Brachytherapy Cryosurgery
1.3.4 Others
1.4 Global Minimally Invasive Prostate Cancer Surgery Market Size & Forecast
1.4.1 Global Minimally Invasive Prostate Cancer Surgery Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Minimally Invasive Prostate Cancer Surgery Sales in Volume (2017-2028)
1.4.3 Global Minimally Invasive Prostate Cancer Surgery Price (2017-2028)
1.5 Global Minimally Invasive Prostate Cancer Surgery Production Capacity Analysis
1.5.1 Global Minimally Invasive Prostate Cancer Surgery Total Production Capacity (2017-2028)
1.5.2 Global Minimally Invasive Prostate Cancer Surgery Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Minimally Invasive Prostate Cancer Surgery Market Drivers
1.6.2 Minimally Invasive Prostate Cancer Surgery Market Restraints
1.6.3 Minimally Invasive Prostate Cancer Surgery Trends Analysis
2 Manufacturers Profiles
2.1 Angiodynamics
2.1.1 Angiodynamics Details
2.1.2 Angiodynamics Major Business
2.1.3 Angiodynamics Minimally Invasive Prostate Cancer Surgery Product and Services
2.1.4 Angiodynamics Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Profound Medical
2.2.1 Profound Medical Details
2.2.2 Profound Medical Major Business
2.2.3 Profound Medical Minimally Invasive Prostate Cancer Surgery Product and Services
2.2.4 Profound Medical Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BSD Medical Corporation
2.3.1 BSD Medical Corporation Details
2.3.2 BSD Medical Corporation Major Business
2.3.3 BSD Medical Corporation Minimally Invasive Prostate Cancer Surgery Product and Services
2.3.4 BSD Medical Corporation Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business
2.4.3 Medtronic Minimally Invasive Prostate Cancer Surgery Product and Services
2.4.4 Medtronic Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Ethicon Endo-Surgery
2.5.1 Ethicon Endo-Surgery Details
2.5.2 Ethicon Endo-Surgery Major Business
2.5.3 Ethicon Endo-Surgery Minimally Invasive Prostate Cancer Surgery Product and Services
2.5.4 Ethicon Endo-Surgery Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Olympus Corporation
2.6.1 Olympus Corporation Details
2.6.2 Olympus Corporation Major Business
2.6.3 Olympus Corporation Minimally Invasive Prostate Cancer Surgery Product and Services
2.6.4 Olympus Corporation Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Siemens Healthcare
2.7.1 Siemens Healthcare Details
2.7.2 Siemens Healthcare Major Business
2.7.3 Siemens Healthcare Minimally Invasive Prostate Cancer Surgery Product and Services
2.7.4 Siemens Healthcare Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Intuitive Surgical
2.8.1 Intuitive Surgical Details
2.8.2 Intuitive Surgical Major Business
2.8.3 Intuitive Surgical Minimally Invasive Prostate Cancer Surgery Product and Services
2.8.4 Intuitive Surgical Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Teleflex
2.9.1 Teleflex Details
2.9.2 Teleflex Major Business
2.9.3 Teleflex Minimally Invasive Prostate Cancer Surgery Product and Services
2.9.4 Teleflex Minimally Invasive Prostate Cancer Surgery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Minimally Invasive Prostate Cancer Surgery Breakdown Data by Manufacturer
3.1 Global Minimally Invasive Prostate Cancer Surgery Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Minimally Invasive Prostate Cancer Surgery Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Minimally Invasive Prostate Cancer Surgery
3.4 Market Concentration Rate
3.4.1 Top 3 Minimally Invasive Prostate Cancer Surgery Manufacturer Market Share in 2021
3.4.2 Top 6 Minimally Invasive Prostate Cancer Surgery Manufacturer Market Share in 2021
3.5 Global Minimally Invasive Prostate Cancer Surgery Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Minimally Invasive Prostate Cancer Surgery Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Minimally Invasive Prostate Cancer Surgery Market Size by Region
4.1.1 Global Minimally Invasive Prostate Cancer Surgery Sales in Volume by Region (2017-2028)
4.1.2 Global Minimally Invasive Prostate Cancer Surgery Revenue by Region (2017-2028)
4.2 North America Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028)
4.3 Europe Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028)
4.4 Asia-Pacific Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028)
4.5 South America Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028)
4.6 Middle East and Africa Minimally Invasive Prostate Cancer Surgery Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Minimally Invasive Prostate Cancer Surgery Sales in Volume by Type (2017-2028)
5.2 Global Minimally Invasive Prostate Cancer Surgery Revenue by Type (2017-2028)
5.3 Global Minimally Invasive Prostate Cancer Surgery Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Minimally Invasive Prostate Cancer Surgery Sales in Volume by Application (2017-2028)
6.2 Global Minimally Invasive Prostate Cancer Surgery Revenue by Application (2017-2028)
6.3 Global Minimally Invasive Prostate Cancer Surgery Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2028)
7.2 North America Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2028)
7.3 North America Minimally Invasive Prostate Cancer Surgery Market Size by Country
7.3.1 North America Minimally Invasive Prostate Cancer Surgery Sales in Volume by Country (2017-2028)
7.3.2 North America Minimally Invasive Prostate Cancer Surgery Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2028)
8.2 Europe Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2028)
8.3 Europe Minimally Invasive Prostate Cancer Surgery Market Size by Country
8.3.1 Europe Minimally Invasive Prostate Cancer Surgery Sales in Volume by Country (2017-2028)
8.3.2 Europe Minimally Invasive Prostate Cancer Surgery Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2028)
9.2 Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2028)
9.3 Asia-Pacific Minimally Invasive Prostate Cancer Surgery Market Size by Region
9.3.1 Asia-Pacific Minimally Invasive Prostate Cancer Surgery Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Minimally Invasive Prostate Cancer Surgery Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2028)
10.2 South America Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2028)
10.3 South America Minimally Invasive Prostate Cancer Surgery Market Size by Country
10.3.1 South America Minimally Invasive Prostate Cancer Surgery Sales in Volume by Country (2017-2028)
10.3.2 South America Minimally Invasive Prostate Cancer Surgery Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales by Type (2017-2028)
11.2 Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales by Application (2017-2028)
11.3 Middle East & Africa Minimally Invasive Prostate Cancer Surgery Market Size by Country
11.3.1 Middle East & Africa Minimally Invasive Prostate Cancer Surgery Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Minimally Invasive Prostate Cancer Surgery Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Minimally Invasive Prostate Cancer Surgery and Key Manufacturers
12.2 Manufacturing Costs Percentage of Minimally Invasive Prostate Cancer Surgery
12.3 Minimally Invasive Prostate Cancer Surgery Production Process
12.4 Minimally Invasive Prostate Cancer Surgery Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Minimally Invasive Prostate Cancer Surgery Typical Distributors
13.3 Minimally Invasive Prostate Cancer Surgery Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer